Literature DB >> 11240673

The management of borderline epithelial tumors of the ovary.

C. W. Burger1, H. M. Prinssen, J. P. A. Baak, N. Wagenaar, P. Kenemans.   

Abstract

The histopathological diagnosis and treatment of borderline epithelial tumors of the ovary (BTO) still pose problems to both pathologists and gynecologists. BTO is a disease of younger, fertile females and generally has an excellent prognosis. A minority of patients, however, succumb to this disease. A review of the literature is given addressing aspects of epidemiology, histology, treatment and prognosis, resulting in a proposal for the management of serous and mucinous borderline tumors of the ovary.

Entities:  

Year:  2000        PMID: 11240673     DOI: 10.1046/j.1525-1438.2000.010003181.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  10 in total

Review 1.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

2.  Aromatase inhibition in relapsing low malignant potential serous tumours of the ovary.

Authors:  Khashayar Esfahani; Cristiano Ferrario; Philippe Le; Lawrence Panasci
Journal:  BMJ Case Rep       Date:  2014-06-12

3.  Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications.

Authors:  Louis Dubeau
Journal:  Transl Cancer Res       Date:  2015-02       Impact factor: 1.241

Review 4.  Surgery for elderly patients with ovarian cancer.

Authors:  Martin G A Bäuerle; Rolf Kreienberg; Tanja Volm
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

5.  Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.

Authors:  Véronique Ouellet; Tak Hay Ling; Karine Normandin; Jason Madore; Christian Lussier; Véronique Barrès; Dimcho Bachvarov; Claudine Rancourt; Patricia N Tonin; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  BMC Cancer       Date:  2008-11-26       Impact factor: 4.430

6.  Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas.

Authors:  J Yu; D Roy; A D Brockmeyer; L Dubeau
Journal:  Br J Cancer       Date:  2007-05-22       Impact factor: 7.640

Review 7.  Controversies in borderline ovarian tumors.

Authors:  Seok Ju Seong; Da Hee Kim; Mi Kyoung Kim; Taejong Song
Journal:  J Gynecol Oncol       Date:  2015-09-23       Impact factor: 4.401

8.  The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women.

Authors:  Fang Shen; Shouzhen Chen; Yifei Gao; Xujing Dai; Qi Chen
Journal:  Oncotarget       Date:  2017-08-22

9.  Develop a nomogram to predict overall survival of patients with borderline ovarian tumors.

Authors:  Xiao-Qin Gong; Yan Zhang
Journal:  World J Clin Cases       Date:  2022-03-06       Impact factor: 1.337

10.  Fertility Sparing Surgery and Borderline Ovarian Tumours.

Authors:  Lorraine S Kasaven; Mehar Chawla; Benjamin P Jones; Maya Al-Memar; Nicolas Galazis; Yousra Ahmed-Salim; Mona El-Bahrawy; Stuart Lavery; Srdjan Saso; Joseph Yazbek
Journal:  Cancers (Basel)       Date:  2022-03-14       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.